China Rush Over? Korean Firms Step Up To Seize Opportunities

Strong BIO Presence Signals Intent

Falling foreign investment and increasing business uncertainties in China could present new opportunities for the Korean biopharma sector, which is stepping up globalization and R&D efforts to seek growth.

business investment
Will Korean Biophamas Benefit From Derailed China Investment Funds? • Source: Shutterstock

With foreign investment in China cooling off this year because of its stringent COVID-19-related policies and multinationals in the country increasingly uncertain over the general business environment, fund in-flows into neighboring Asian countries are increasing.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from South Korea

More from Focus On Asia